NextGen Ventures

NextGen Ventures is a venture capital firm established in 2011 and located in Ede, Netherlands. The firm specializes in investing in the medtech and healthcare information technology sectors, focusing specifically on companies within the Netherlands. By targeting innovative businesses in digital healthcare, NextGen Ventures aims to support the development and growth of technologies that can enhance healthcare delivery and improve patient outcomes.

Peter Haasjes

Investment Manager

9 past transactions

STENTiT

Seed Round in 2022
Regenerative Stents

EQUO

Seed Round in 2022
EQUO creates a product that has minimal impact on the environment. It provides a variety of truly eco-friendly solutions for everyday items by providing products that are 100% natural, plastic-free, non-toxic, chemical-free & biodegradable, and compostable.

Manometric

Seed Round in 2021
Manometric B.V., located in Delft, the Netherlands, specializes in the 3D printing of customized hand braces. The company develops innovative technology for orthotic and prosthetic instruments, utilizing a proprietary instant 3D hand scanner and advanced automation software. This enables orthopedic specialists to design and produce comfortable, aesthetically pleasing hand braces tailored to individual patient needs. By combining cutting-edge 3D software with unique design capabilities, Manometric facilitates the creation of personalized solutions for medical professionals, enhancing both functionality and patient comfort.

LeQuest

Venture Round in 2019
LeQuest has developed a software platform that enables healthcare professionals to be trained in the use of (complex) medical equipment. Several separate modules have been developed within the platform, in which medical equipment is fully digitally reproduced, including the functionalities of the device in question. The healthcare sector is faced with increasing dependence on (complex) medical technology. By using the LeQuest software, a healthcare institution can provide competence management and knowledge management for its staff. The following matters are guaranteed: certification, registration and retraining for specific (complex) medical equipment.

ENPICOM

Series A in 2019
ENPICOM is an innovative bioinformatics software engineering company dedicated to supporting scientists in biopharma and academic research centers with groundbreaking products and customized solutions to improve and accelerate the discovery and development of novel immunotherapies and vaccines. Leveraging a unique mix of biological knowledge, bioinformatics method development, and software engineering skills, ENPICOM developed the ImmunoGenomiX (IGX) Platform, an innovative platform to manage, store, analyze, visualize, and compare immune repertoire sequencing data from T and B cell receptors

Plasmacure

Seed Round in 2018
Plasmacure specializes in the development of a technology to treat diabetic food wounds. Plasmacure is based in Eindhoven, the Netherlands.

Alledaags

Seed Round in 2018
Everyday makes applications that you want to use every day. They believe that impact and success lie in connecting digitally with everyday things. More convenience in a process, more fun working or easier contact.

Plasmacure

Pre Seed Round in 2016
Plasmacure specializes in the development of a technology to treat diabetic food wounds. Plasmacure is based in Eindhoven, the Netherlands.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.